NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/26/2024
Back to search
Official data from USPTO
TRANSTHERA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
11/26/2024
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
07/01/2022
Registration date
11/26/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/26/2024
Last transaction
11/26/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
3
Owner type
03
Owner location
Nanjing, CN
Examiner
MAYES, LAURIE ANN
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "TransThera", wherein the stylized letter "n" in the wording has an elongated right side and a design with stylized leaves above and a curved line above the middle of the mark.
Holders and representatives
Holders
TransThera Sciences (Nanjing), Inc.
Representatives
Jinggao LI DRAGON SUN LAW FIRM, P. C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines; Chemical preparations for pharmaceutical or medical purposesfor treatment of cancercardiovascular diseases and disordersmetabolic diseases and disordersanemia and associated anemia diseases and disordersrespiratory diseases and disordersgastrointestinal diseases and disordersnervous system diseases and disordersinfection and inflammationskeletal or chondrocyte disordersimmune and autoimmune diseaseshematological disorders; Medicines for alleviating constipation; Medicines for intestinal disorders; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancercardiovascular diseases and disordersmetabolic diseases and disordersanemia and associated anemia diseases and disordersrespiratory diseases and disordersgastrointestinal diseases and disordersnervous system diseases and disordersinfection and inflammationskeletal or chondrocyte disordersimmune and autoimmune diseaseshematological disorders
Publications
History of USPTO decisions and trademark events.
37 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/24/2024
PUBO
PUBLISHED FOR OPPOSITION
09/24/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/04/2024
OTHE
CASE RETURNED TO EXAMINATION
08/19/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
08/19/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
08/15/2024
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
08/15/2024
APET
ASSIGNED TO PETITION STAFF
08/15/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/15/2024
EX2G
SOU EXTENSION 2 GRANTED
08/15/2024
NREV
NOTICE OF REVIVAL - E-MAILED
08/08/2024
PGEX
PETITION GRANTED - EXTENSION REQUEST FILED
08/08/2024
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
07/22/2024
PILM
PETITION INQUIRY LETTER ISSUED
07/11/2024
APET
ASSIGNED TO PETITION STAFF
07/10/2024
EXT2
SOU EXTENSION 2 FILED
06/06/2024
44EP
44(e) PETITION - RECEIVED
06/05/2024
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
06/05/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/24/2023
EX1G
SOU EXTENSION 1 GRANTED
11/22/2023
EXT1
SOU EXTENSION 1 FILED
11/22/2023
EEXT
SOU TEAS EXTENSION RECEIVED
11/22/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/06/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/11/2023
PUBO
PUBLISHED FOR OPPOSITION
04/11/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/22/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/02/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
03/02/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/02/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
03/02/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/02/2023
DOCK
ASSIGNED TO EXAMINER
02/25/2023
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/23/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/22/2022
NWAP
NEW APPLICATION ENTERED
07/05/2022
Continuous trademark protection
Get notified about every new filing that threatens TRANSTHERA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.